Literature DB >> 22816434

Sensibility assessment of the HIV Disability Questionnaire.

Kelly K O'Brien1, Ahmed M Bayoumi, Tarik Bereket, Marilyn Swinton, Rob Alexander, Kenneth King, Patricia Solomon.   

Abstract

PURPOSE: Our purpose was to assess the sensibility of the human immunodeficiency virus (HIV) Disability Questionnaire (HDQ), the first HIV-specific disability questionnaire.
METHODS: We administered the HDQ, a sensibility questionnaire and a structured qualitative interview to 22 adults living with HIV and five experienced clinicians. We considered the HDQ sensible if median scores on the sensibility questionnaire were ≥5 for adults living with HIV and ≥4 for clinicians for at least 80% of the items. We analyzed the interview data using directed qualitative content analytical techniques.
RESULTS: Questionnaire scores were ≥5 for 88% (15/17) of the items and ≥4 for 100% (17/17) of the items for adults living with HIV and clinicians, respectively. The interview analysis indicated participants felt the HDQ possessed face and content validity in all disability dimensions, had adequate response options, was easy to complete, and adequately captured the episodic nature of disability. Participants had mixed responses about the questionnaire title and provided recommendations to refine item wording and response options.
CONCLUSIONS: The HDQ appears sensible for use with adults living with HIV. Next steps include further measurement property assessment. The HDQ may be used by rehabilitation clinicians and researchers to assess disability experienced by adults living with HIV. IMPLICATIONS FOR REHABILITATION: • As people with HIV infection live longer, individuals may face a range of health-related challenges due to the disease, concurrent health conditions and the potential adverse effects of treatment. Together, these health-related challenges may be termed disability. • The HIV Disability Questionnaire (HDQ) is the first HIV-specific instrument developed to describe the presence, severity and episodic nature of the disability experienced by adults living with HIV. The HDQ is comprised of four domains including symptoms and impairments, uncertainty about future health, difficulties carrying out day-to-day activities, and challenges to social inclusion. • The HDQ appears sensible for use with adults living with HIV, possessing face and content validity and ease of use in all four domains as well as describing the daily episodic nature of disability. • The HDQ may be used by rehabilitation clinicians and researchers to assess disability experienced by adults living with HIV.

Entities:  

Mesh:

Year:  2012        PMID: 22816434     DOI: 10.3109/09638288.2012.702848

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  13 in total

Review 1.  A Review of HIV-Specific Patient-Reported Outcome Measures.

Authors:  Kim Engler; David Lessard; Bertrand Lebouché
Journal:  Patient       Date:  2017-04       Impact factor: 3.883

2.  Development of the gait outcomes assessment list for lower-limb differences (GOAL-LD) questionnaire: a child and parent reported outcome measure.

Authors:  F Virginia Wright; Unni G Narayanan; Jennifer A Dermott; Nancy M Salbach
Journal:  Health Qual Life Outcomes       Date:  2021-05-05       Impact factor: 3.186

3.  HIV and childhood disability: a case-controlled study at a paediatric antiretroviral therapy centre in Lilongwe, Malawi.

Authors:  Akash Devendra; Atupele Makawa; Peter N Kazembe; Nancy R Calles; Hannah Kuper
Journal:  PLoS One       Date:  2013-12-31       Impact factor: 3.240

4.  Advancing research and practice in HIV and rehabilitation: a framework of research priorities in HIV, disability and rehabilitation.

Authors:  Kelly K O'Brien; Francisco Ibáñez-Carrasco; Patricia Solomon; Richard Harding; Jessica Cattaneo; William Chegwidden; Jacqueline Gahagan; Larry Baxter; Catherine Worthington; Patriic Gayle; Brenda Merritt; Rosalind Baltzer-Turje; Nkem Iku; Elisse Zack
Journal:  BMC Infect Dis       Date:  2014-12-31       Impact factor: 3.090

5.  Measuring disability experienced by adults living with HIV: assessing construct validity of the HIV Disability Questionnaire using confirmatory factor analysis.

Authors:  Kelly K O'Brien; Patricia Solomon; Ahmed M Bayoumi
Journal:  BMJ Open       Date:  2014-09-01       Impact factor: 2.692

6.  Evaluating a community-based exercise intervention with adults living with HIV: protocol for an interrupted time series study.

Authors:  Kelly K O'Brien; Ahmed M Bayoumi; Patricia Solomon; Ada Tang; Kate Murzin; Soo Chan Carusone; Mehdi Zobeiry; Ayesha Nayar; Aileen M Davis
Journal:  BMJ Open       Date:  2016-10-20       Impact factor: 2.692

7.  Reliability and Validity of the HIV Disability Questionnaire (HDQ) with Adults Living with HIV in the United States.

Authors:  Kelly Kathleen O'Brien; David Kietrys; Mary Lou Galantino; James Scott Parrott; Tracy Davis; Quang Tran; Rachel Aubry; Patricia Solomon
Journal:  J Int Assoc Provid AIDS Care       Date:  2019 Jan-Dec

8.  Developing a short-form version of the HIV Disability Questionnaire (SF-HDQ) for use in clinical practice: a Rasch analysis.

Authors:  Kelly K O'Brien; Mendwas Dzingina; Richard Harding; Wei Gao; Eve Namisango; Lisa Avery; Aileen M Davis
Journal:  Health Qual Life Outcomes       Date:  2021-01-06       Impact factor: 3.186

9.  Reliability and validity of a new HIV-specific questionnaire with adults living with HIV in Canada and Ireland: the HIV Disability Questionnaire (HDQ).

Authors:  Kelly K O'Brien; Patricia Solomon; Colm Bergin; Siobhán O'Dea; Paul Stratford; Nkem Iku; Ahmed M Bayoumi
Journal:  Health Qual Life Outcomes       Date:  2015-08-12       Impact factor: 3.186

10.  Japanese medical learners' achievement emotions: Accounting for culture in translating Western medical educational theories and instruments into an asian context.

Authors:  Osamu Nomura; Jeffrey Wiseman; Momoka Sunohara; Haruko Akatsu; Susanne P Lajoie
Journal:  Adv Health Sci Educ Theory Pract       Date:  2021-05-12       Impact factor: 3.853

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.